Navigation Links
Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis

tional-hazards analysis.

This news release contains forward-looking statements regarding eprodisate (KIACTA(TM)), as well as regarding continuing and further development efforts. These statements are based on the current analysis and expectations of management. Drug development necessarily involves numerous risks and uncertainties, which could cause actual results to differ materially from this current analysis and these expectations. Analysis regarding the results of clinical trials may not provide definitive results regarding safety, tolerability or therapeutic benefits. There is no certainty that regulators will ultimately approve eprodisate (KIACTA(TM)) for sale to the public. Risks and uncertainties may include: failure to demonstrate the safety, tolerability and efficacy of our product, that actual results may vary once the final and quality-controlled verification of data and analyses has been completed, the expense and uncertainty of obtaining regulatory approval, including from the FDA, and the possibility of having to conduct additional clinical trials. Further, even if regulatory approval is obtained, therapeutic products are generally subject to: stringent on-going governmental regulation, challenges in gaining market acceptance, and competition. Neither Neurochem Inc., nor Neurochem (International) Limited undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise. Please see Neurochem Inc.'s Annual Information Form for further risk factors that might affect Neurochem Inc., Neurochem (International) Limited and their respective businesses.

    For further information, please contact:


    Lise Hebert, PhD                        (450) 680-4572

    Vice President, Corporate

    Communications                          

lhebert@neurochem.com

CONTACT: Lise Hebert, PhD, Vice President,
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
Post Your Comments:
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)... Pa. , March 4, 2015  Results of ... 100 Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin ... poster session at the 32 nd Annual Miami ... study, conducted by Moshe Papa , MD, FACS, ... at Tel Aviv University, reports an analysis of MarginProbe,s ...
(Date:3/4/2015)... 4, 2015   HeartWare International, Inc . (NASDAQ: ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... Doug Godshall is scheduled to present at ... Eastern Time on Tuesday, March 10, 2015.  The conference ... Beach Hotel in Florida . ...
Breaking Medicine Technology:XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2
... Fla., Aug. 17, 2011 Stryker Corporation,s Orthopaedics ... orthopaedics, today announced an agreement in which OrthoSensor ... use with Stryker,s Triathlon Knee System. The OrthoSensor ... quantitative, intra-operative feedback to surgeons to optimize joint ...
... Aug. 17, 2011 Thousands of people with ... will attend Abilities Expo on Friday, August 26, through Sunday, ... show hours are Friday 11 am to 5 pm, Saturday ... 4 pm. Abilities Expo has put together an ...
Cached Medicine Technology:Stryker Orthopaedics Enters into Agreement with OrthoSensor for Intelligent Surgical Platform 2Stryker Orthopaedics Enters into Agreement with OrthoSensor for Intelligent Surgical Platform 3Abilities Expo, the Nation's Largest Event for People With Disabilities and Their Caregivers, Is Coming to the Houston Area on August 26-28 2
(Date:3/4/2015)... The Alliance for Regenerative Medicine (ARM) ... fifth annual Advanced Therapies Summit next Thursday, March ... year will feature five expert-led interactive roundtables with ... leading companies and organizations. , This one-day ... researchers from the advanced therapies community across Europe ...
(Date:3/4/2015)... Saint Petersburg, Florida and Dayton, Ohio (PRWEB) March 04, ... who was nearly killed in an IED explosion in ... went through while recovering. He received some free Chiropractic ... was introduced to Magnetic Resonance Therapy. , This is ... beginning treatment using the Magnesphere, I have clarity, I ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... non-profit WaterAid a total of $6.9 million, ... in Ghana, Mali, Niger and Burkina Faso. , The ... two areas. The first will focus on fixing water ... improving the skills of local people to maintain water ...
(Date:3/4/2015)... March 04, 2015 i2i Systems ... selected by Chase Brexton Health Care, a 35-year-old ... , Chase Brexton provides comprehensive primary care, behavioral ... patients across seven clinics in the greater Baltimore ... electronic medical records, the organization has always focused ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nike Swim ... and staff whose mission is to stimulate a love ... “Nike Swim Camps provide campers the opportunity to train ... nation,” says Paul Merrion, Vice President of US Sports ... enabling each swimmer to build confidence and improve their ...
Breaking Medicine News(10 mins):Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 2Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2
... a diet that consists of healthy foods, including almonds, ... drugs. Researchers say incorporating almonds // into one’s ... easiest substitutions to try might include a snack of ... ,Researchers from Toronto studied a group of people with ...
... less oxygen to the body after the first few minutes ... minutes // of exercise, the amount of oxygen per ... the oxygen to the blood. ,Researchers studied nearly ... hypertension. Researchers measured the patients’ heart sizes and performance at ...
... recent study shows only 7 percent of diabetics ... and blood vessel problems. // Researchers stressed continued ... disease including retinopathy, neuropathy, nephropathy, coronary heart disease, ... nearly 1,700 adults, ages 20 years or older, ...
... is second only to smoking as a risk factor ... respiratory disease and heart attacks increases. Healthy lungs usually ... by 1 percent every year after age 20. ... of Environmental Health Sciences, children who live in heavily ...
... in a cardiac-rehab program after a heart attack had about ... same age and sex who had not had a heart ... occurred among patients in their study were due to not ... about 1,800 patients. Nearly 60 percent participated in cardiac rehab ...
... provides evidence that a low-glycemic index diet can lead ... risk factors of diabetes and cardiovascular disease. In low-GI ... slowly.// High-GI foods, which include white bread, refined breakfast ... blood glucose and insulin to high levels. Carbs that ...
Cached Medicine News:
... SkanWasher 400 is an ... washer with built-in pressure ... individual pressure settings allow ... gentle wash to a ...
Lab-Reader...
Fully automatic NRTL and CE certified microplate reader....
... compact and versatile multilabel microplate ... allows up to six measurement ... luminescence, absorbance, and fluorescence including ... fluorescence polarization all on the ...
Medicine Products: